Anti-angiogenics can correct hypoxia in breast and lung tumors
Normoxic tumors shut down glycolysis and rely on mitochondrial metabolism
Mitochondrial metabolism is essential for tumor survival when normoxic
Targeting mitochondrial metabolism is synergistic with antiangiogenics